Alpha-lipoic acid supplement before IVF in older women with diminished ovarian reserve
Tests alpha-lipoic acid before IVF in infertile women with diminished ovarian reserve.
Key facts
- Who runs it
- Kaohsiung Veterans General Hospital.
- Where
- Taiwan1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Alpha-Lipoic Acid Supplementation and IVF Outcomes in Women of Advanced Maternal Age
- Status
- Recruiting
- People taking part
- 60 people, planned
- Started
- 11 Jun 2026
- Expected to end
- 30 Jun 2028
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Alpha-Lipoic Acid (ALA)
- Record updated
- 7 July 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for women aged 35-45 years with infertility who plan IVF using their own eggs. Some will take alpha-lipoic acid 600 mg/day for 2 months before IVF, others will go straight to IVF.
- Age
- 35 to 45 years
- Sex
- Women only
- Disease stage
- Infertility in women of older reproductive age who plan IVF with their own eggs. BMI 18-35 kg/m².
Main reasons for not taking part
- Early loss of ovary function (primary ovarian insufficiency)
- Partner with no sperm or severe male-factor infertility
- Uterus shape problem from birth, or severe scarring inside the uterus
- Known chromosome problem in either partner, or cancer
- Using donor eggs, or allergy to alpha-lipoic acid
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Age 35-45 years
- BMI 18-35 kg/m²
- Planning to undergo IVF treatment using own oocytes
Who cannot take part
- Primary ovarian insufficiency
- Malignancy
- Known hypersensitivity/allergy to alpha-lipoic acid
- Azoospermia or severe male-factor infertility in the partner
- Congenital uterine anomaly
- Severe intrauterine adhesion
- Known chromosomal anomaly in either partner
- Recipient of donor oocytes
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 35 and 45 years old?
This trial is currently available in Taiwan.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Female fertility declines with advancing age, largely because of deteriorating oocyte quality driven by mitochondrial dysfunction and oxidative stress within the ovarian microenvironment. Alpha-lipoic acid (ALA) is a potent antioxidant that crosses cell and mitochondrial membranes, regenerates other antioxidants (vitamin C, vitamin E, glutathione, coenzyme Q10), and supports mitochondrial respiratory chain activity and ATP production. This prospective study will enroll 60 infertile women aged 35-45 years undergoing in vitro fertilization (IVF) treatment. Thirty participants will receive oral ALA 600 mg/day for two months before their IVF cycle, and thirty will proceed directly to IVF without supplementation. The study will compare oocyte and embryo quality, cumulus cell mitochondrial function and metabolic gene expression, and clinical pregnancy and live birth rates between the two groups.
The 2 groups in the trial
- Alpha-Lipoic Acid + IVFTreatment being tested
Participants receive oral alpha-lipoic acid 600 mg/day for 2 months, followed by a standard controlled ovarian stimulation IVF cycle
Treatment: Alpha-Lipoic Acid (ALA)
- Standard IVF (Control)No study treatment, for comparison
Participants proceed directly to a standard controlled ovarian stimulation IVF cycle without alpha-lipoic acid or any other antioxidant supplementation.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effects of Alpha-Lipoic Acid Supplementation on Oocyte Quality, Cumulus Cell Mitochondrial Function, and In Vitro Fertilization Outcomes in Infertile Women of Advanced Maternal Age: A Prospective Cohort Study
- Plain-language title
- Alpha-lipoic acid supplement before IVF in older women with diminished ovarian reserveGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Criteria questions
- Built from NCT07685431, who can take part
- Record updated
- 7 July 2026